Fineline Cube

Follow:
14398 Articles
Innovent Biologics and ASK Pharma Forge Strategic Partnership for Limertinib in Lung Cancer Treatment
CompanyDeals

Innovent Biologics and ASK Pharma Forge Strategic Partnership for Limertinib in Lung Cancer Treatment

MediLink Therapeutics Partners with Amgen for Clinical Trial in Small Cell Lung Cancer
CompanyDeals

MediLink Therapeutics Partners with Amgen for Clinical Trial in Small Cell Lung Cancer

Cassava Sciences to Pay Over USD 40 Million to Settle SEC Charges Over Alzheimer’s Drug Claims
Company

Cassava Sciences to Pay Over USD 40 Million to Settle SEC Charges Over Alzheimer’s Drug Claims

Wuhan YZY Biopharma Grants Rights to CD3/EpCAM Antibody M701 to Chi Ta TianQing Pharma in China
CompanyDeals

Wuhan YZY Biopharma Grants Rights to CD3/EpCAM Antibody M701 to Chi Ta TianQing Pharma in China

Regor Therapeutics Strikes Deal with Genentech for CDK Inhibitors, Fetching USD 850 Million Upfront
CompanyDeals

Regor Therapeutics Strikes Deal with Genentech for CDK Inhibitors, Fetching USD 850 Million Upfront

China's CDE Announces "Care Plan" to Include Pfizer's Marstaximab for Rare Disease Drug Development
CompanyDrug

China’s CDE Announces “Care Plan” to Include Pfizer’s Marstaximab for Rare Disease Drug Development

Genor Biopharma to Acquire EOC Pharma Group in a Merger Deal, Eyeing Commercialization Synergies
CompanyDeals

Genor Biopharma to Acquire EOC Pharma Group in a Merger Deal, Eyeing Commercialization Synergies

WuXi AppTec and WuXi Biologics Weigh Asset Sales in US and Europe Over Biosecure Act Concerns
Company

WuXi AppTec and WuXi Biologics Weigh Asset Sales in US and Europe Over Biosecure Act Concerns

Tigermed Announces Acquisition of Majority Stake in Shanghai Guanhe Pharmaceutical for CNY 140 Million
CompanyDeals

Tigermed Announces Acquisition of Majority Stake in Shanghai Guanhe Pharmaceutical for CNY 140 Million

China's National Healthcare Security Administration Issues Draft Guidelines for Long-Term Care Insurance
Policy / Regulatory

China’s National Healthcare Security Administration Issues Draft Guidelines for Long-Term Care Insurance

Insilico Medicine and Seto Biopartner to Leverage AI in Synthetic Biology and Drug Discovery
CompanyDeals

Insilico Medicine and Seto Biopartner to Leverage AI in Synthetic Biology and Drug Discovery

China's CDE Releases Draft Guidelines for Biosimilar Drug Labeling
Policy / Regulatory

China’s CDE Releases Draft Guidelines for Biosimilar Drug Labeling